647 drugs are under incentive plans for substituted dispensing.
Published: 2004-01-14 06:57:00
Updated: 2004-01-14 06:57:00
As of the end of Dec. last year the total 647 drugs were proven of its bio-equivalency by the KFDA and therefore privileged to get incentive plans when substituted to prescription drugs according to HIRA's official announcement on Jan. 12.
The official statement indicates that the total number...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
